Covered recipient · General Payments record
MARYJO E PAUL
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2024
$362.55
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $362.55 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $113.49 | 5 |
| Astellas Pharma US Inc | $45.50 | 2 |
| Sumitomo Pharma America, Inc. | $44.49 | 2 |
| ABBVIE INC. | $42.78 | 2 |
| PFIZER INC. | $35.80 | 2 |
| Lilly USA, LLC | $29.49 | 2 |
| Exact Sciences Corporation | $26.84 | 1 |
| Medtronic, Inc. | $24.16 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $362.55 | 17 |
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.36 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105214734 | CMS |
| ABBVIE INC. | $15.42 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105214738 | CMS |
| Amgen Inc. | $27.23 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117349756 | CMS |
| Amgen Inc. | $23.07 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117349760 | CMS |
| Amgen Inc. | $14.89 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117651692 | CMS |
| Amgen Inc. | $27.39 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117349758 | CMS |
| Amgen Inc. | $20.91 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117651694 | CMS |
| Astellas Pharma US Inc | $21.35 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139472472 | CMS |
| Astellas Pharma US Inc | $24.15 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139538542 | CMS |
| Exact Sciences Corporation | $26.84 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128380932 | CMS |
| Lilly USA, LLC | $15.50 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135817602 | CMS |
| Lilly USA, LLC | $13.99 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135817604 | CMS |
| Medtronic, Inc. | $24.16 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117034361 | CMS |
| PFIZER INC. | $15.37 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131581777 | CMS |
| PFIZER INC. | $20.43 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131505586 | CMS |
| Sumitomo Pharma America, Inc. | $24.79 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148986998 | CMS |
| Sumitomo Pharma America, Inc. | $19.70 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148987000 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.